Stoner Eric J, Peterson Matthew J, Allen Michael S, DeMattei John A, Haight Anthony R, Leanna M Robert, Patel Subhash R, Plata Daniel J, Premchandran Ramiya H, Rasmussen Michael
Global Pharmaceutical Research and Development, Abbott Laboratories, 1401 Sheridan Road, North Chicago, IL 60064-6290, USA.
J Org Chem. 2003 Nov 14;68(23):8847-52. doi: 10.1021/jo034883z.
Functionalized erythromycin 9-oxime derivatives are 6-O-allylated under mild conditions using substituted allyl tert-butyl carbonates under palladium(0) catalysis. This allylation works well where traditional ether-forming protocols function poorly. Allyl tert-butyl carbonates provide higher yields in this reaction than lesser substituted carbonates such as ethyl or isopropyl. Aryl-substituted allyl carbonates or carbamates may be employed as well and, when used, produce trans-olefinic products.
在钯(0)催化下,使用取代的烯丙基叔丁基碳酸酯,功能化的红霉素9-肟衍生物在温和条件下进行6-O-烯丙基化反应。这种烯丙基化反应在传统成醚方法效果不佳的情况下表现良好。烯丙基叔丁基碳酸酯在该反应中比取代程度较低的碳酸酯(如乙基或异丙基碳酸酯)能提供更高的产率。芳基取代的烯丙基碳酸酯或氨基甲酸酯也可使用,使用时会生成反式烯烃产物。